BIG PHARMA WATCH: U.S. HOUSE REPORT DETAILS “UNJUSTIFIABLY HIGH PRICE” OF UNPROVEN ALZHEIMER’S DRUG ADUHELM
Jan 3, 2023
Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to… Read More
© 2025 CSRXP- All Rights Reserved
Blog Posts
DOSE OF REALITY: BREAKING DOWN BIG PHARMA’S YEAR OF BAD BEHAVIOR IN 2022
Dec 28, 2022
Get the Facts on Big Pharma’s Year of Out-of-Control Launch Prices… Read More
TWO BIRDS OF A FEATHER: BIG PHARMA PRICE HIKERS TO JOIN FORCES IN LARGEST HEALTH CARE MERGER OF THE YEAR
Dec 13, 2022
Amgen and Horizon Therapeutics Eye Merger As Both Continue to Hike Prices on… Read More
SECOND OPINION: BIG PHARMA EXEC BOOED AS HE DISMISSES AFFORDABILITY CONCERNS ON HIGH PRICED TREATMENTS AS “LUDICROUS”
Dec 9, 2022
Regeneron Co-Founder Says, “Forget About That” When Pressed on How… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN DRUGS COST U.S. $805 MILLION IN 2021
Dec 7, 2022
Brand Name Drug Companies Continue Raising Prices on Blockbuster Products With… Read More
BIG PHARMA WATCH: MERCK PLOTS TO FURTHER BLOCK COMPETITION AND EXTEND MONOPOLY PRICING ON BLOCKBUSTER CANCER DRUG KEYTRUDA
Dec 2, 2022
Big Pharma Giant Wants New Patents for Formulation Changes That Won’t… Read More
BIG PHARMA WATCH: DRUG COMPANY VERTEX PRICE-GOUGING BRAND NAME CYSTIC FIBROSIS TREATMENTS AND BANKING HUGE PROFITS
Nov 30, 2022
Patient Advocates Warn Access to Egregiously Priced Treatments at Risk Drug… Read More
TWO BIRDS OF A FEATHER: BIG PHARMA COMPANIES EYE MERGER TO UNDERMINE GENERIC COMPETITION TO OPIOID TREATMENTS
Nov 16, 2022
Brand Name Drug Company to Acquire Manufacturer of Narcan as Both Work to… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE, AMGEN, ASTRAZENECA
Nov 11, 2022
Big Pharma Giants Notch Expectation-Busting Earnings After Continuing to Hike… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE, SANOFI, ELI LILLY
Nov 4, 2022
Big Pharma Giants Beat Wall Street Expectations After Year of Price Increases,… Read More
BIG PHARMA WATCH: REPRESENTATIVE KATIE PORTER HIGHLIGHTS BIG PHARMA’S OUTRAGEOUS CANCER DRUG LAUNCH PRICES
Nov 3, 2022
New Report Finds Brand Name Drug Companies Increased Prices on New Oncology… Read More
DOSE OF REALITY: NEW STUDY UNDERSCORES BIG PHARMA’S PRICING PRACTICES ARE ABOUT PROFITS, NOT VALUE FOR PATIENTS
Nov 1, 2022
JAMA Analysis Finds No Correlation Between Cancer Drug Prices and… Read More